Product

4D-125

Aliases

4D-125 IVT Injection

1 clinical trial

1 indication

Indication

Retinitis Pigmentosa

Clinical trial

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-125 in Males With X-linked Retinitis Pigmentosa (XLRP) Caused by Mutations in the RPGR Gene

Status: Active (not recruiting), Estimated PCD: 2026-06-01